Jacobio Pharmaceuticals Group Co., Ltd.

SEHK:1167 Stok Raporu

Piyasa değeri: HK$1.2b

Jacobio Pharmaceuticals Group Yönetim

Yönetim kriter kontrolleri 3/4

Jacobio Pharmaceuticals Group CEO'su Yinxiang Wang, Aug2019 tarihinde atandı, in görev süresi 5.25 yıldır. in toplam yıllık tazminatı CN¥ 3.42M olup, şirket hissesi ve opsiyonları dahil olmak üzere 77.3% maaş ve 22.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 13.63% ine doğrudan sahiptir ve bu hisseler HK$ 165.63M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.8 yıl ve 4.3 yıldır.

Anahtar bilgiler

Yinxiang Wang

İcra Kurulu Başkanı

CN¥3.4m

Toplam tazminat

CEO maaş yüzdesi77.3%
CEO görev süresi5.3yrs
CEO sahipliği13.6%
Yönetim ortalama görev süresi4.8yrs
Yönetim Kurulu ortalama görev süresi4.3yrs

Son yönetim güncellemeleri

Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

May 31
Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

Recent updates

Does Jacobio Pharmaceuticals Group (HKG:1167) Have A Healthy Balance Sheet?

Nov 24
Does Jacobio Pharmaceuticals Group (HKG:1167) Have A Healthy Balance Sheet?

Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

May 31
Most Shareholders Will Probably Agree With Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) CEO Compensation

Is Jacobio Pharmaceuticals Group (HKG:1167) Using Debt Sensibly?

May 29
Is Jacobio Pharmaceuticals Group (HKG:1167) Using Debt Sensibly?

We're Hopeful That Jacobio Pharmaceuticals Group (HKG:1167) Will Use Its Cash Wisely

May 10
We're Hopeful That Jacobio Pharmaceuticals Group (HKG:1167) Will Use Its Cash Wisely

Time To Worry? Analysts Are Downgrading Their Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Outlook

Aug 26
Time To Worry? Analysts Are Downgrading Their Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Outlook

We're Not Very Worried About Jacobio Pharmaceuticals Group's (HKG:1167) Cash Burn Rate

Jul 29
We're Not Very Worried About Jacobio Pharmaceuticals Group's (HKG:1167) Cash Burn Rate

We Think Jacobio Pharmaceuticals Group (HKG:1167) Can Afford To Drive Business Growth

Apr 29
We Think Jacobio Pharmaceuticals Group (HKG:1167) Can Afford To Drive Business Growth

What Percentage Of Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Shares Do Insiders Own?

Mar 21
What Percentage Of Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Shares Do Insiders Own?

CEO Tazminat Analizi

Yinxiang Wang'un ücretlendirmesi Jacobio Pharmaceuticals Group'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CN¥362m

Mar 31 2024n/an/a

-CN¥361m

Dec 31 2023CN¥3mCN¥3m

-CN¥359m

Sep 30 2023n/an/a

-CN¥385m

Jun 30 2023n/an/a

-CN¥410m

Mar 31 2023n/an/a

-CN¥391m

Dec 31 2022CN¥4mCN¥2m

-CN¥372m

Sep 30 2022n/an/a

-CN¥332m

Jun 30 2022n/an/a

-CN¥292m

Mar 31 2022n/an/a

-CN¥297m

Dec 31 2021CN¥4mCN¥2m

-CN¥301m

Tazminat ve Piyasa: Yinxiang 'nin toplam tazminatı ($USD 471.44K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 347.90K ).

Tazminat ve Kazançlar: Yinxiang 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Yinxiang Wang (59 yo)

5.3yrs

Görev süresi

CN¥3,415,000

Tazminat

Dr. Yinxiang Wang serves as Consultant at Shining Capital. He is an Executive Chairman at Jacobio Pharmaceuticals Co. Ltd. since August 20, 2020.Dr. Wang has been Director at Jacobio Pharmaceuticals Co. L...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Yinxiang Wang
Executive Chairman & CEO5.3yrsCN¥3.42m13.63%
HK$ 165.6m
Xiaojie Wang
Executive Director & President of Administration9.2yrsCN¥2.55m2.91%
HK$ 35.3m
Yunyan Hu
Executive VP & Executive Director5.7yrsCN¥2.51m2.95%
HK$ 35.9m
Tao Yang
Vice President of Human Resourcesno dataVeri yokVeri yok
Andrea Wang-Gillam
Executive VP4.3yrsVeri yokVeri yok
Yanping Wang
Executive Vice President of Non-Clinical R&Dno dataVeri yokVeri yok
Haijun Wang
Senior Vice President of Information & Data Managementno dataVeri yokVeri yok
Yuli Ding
Executive Vice President of Clinical Developmentno dataVeri yokVeri yok
Qing Xue
Joint Company Secretary4.3yrsVeri yokVeri yok
Ming Fai Chung
Joint Company Secretary2.3yrsVeri yokVeri yok

4.8yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: 1167 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.8 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Yinxiang Wang
Executive Chairman & CEO6.4yrsCN¥3.42m13.63%
HK$ 165.6m
Xiaojie Wang
Executive Director & President of Administration6.3yrsCN¥2.55m2.91%
HK$ 35.3m
Yunyan Hu
Executive VP & Executive Director6.3yrsCN¥2.51m2.95%
HK$ 35.9m
Ge Wu
Independent Non-Executive Director4.3yrsCN¥200.00kVeri yok
Ruilin Song
Independent Non-Executive Director4.3yrsCN¥400.00kVeri yok
Te-li Chen
Non Executive Director4.3yrsVeri yokVeri yok
Bai Lu
Independent Non-Executive Director1.7yrsCN¥150.00kVeri yok

4.3yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1167 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).